hotspot -WSS

hotspot

author：leisure time 2025-08-08 10:31:34 - browse：53266

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Erich Jarvis studies song birds to learn about human stuttering

focus

WSS

South Korea throws huge K

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Pregnancy ages women, but effects reverse after delivery

Naloxone nonprofit donates 200,000 doses after FDA approval

focus

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Adam's Take: Intra

Continuity nursing helped my family in our darkest PICU moments

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Yancopoulos of Regeneron works to expand Dupixent success

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

U.K. officials, researchers try to ease path for bespoke genetic treatments

What does generative AI mean for health care? We asked experts

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

focus

What to know about Virgin Galactic's 1st mission taking paying customers to space

Emergent cuts jobs, executive role in business shake

American woman, child freed after being kidnapped in Haiti last month

Erich Jarvis studies song birds to learn about human stuttering

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

American woman, child freed after being kidnapped in Haiti last month

hotspot

hotspot

focus

Wikipedia